Label Changes for:

Tenex (guanfacine hydrochloride) Tablets

July 2013

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

PRECAUTIONS

Pediatric Use
  • Hallucinations have been reported in pediatric patients receiving Tenex for treatment of attention-deficit hyperactivity disorder
Hide
(web1)